Article

USP Publishes General Chapter 1220 of Analytical Procedure Life Cycle

USP is publishing the analytics-focused chapter, which considers validation activities, in advance of the official publication.

The United States Pharmacopeia announced on Sept, 24, 2021, that it is publishing the approved General Chapter <1220> “Analytical Procedure Life Cycle”. The new chapter considers the validation activities that occur throughout the life cycle of an analytical procedure.

This chapter is being published in advance of the official publication posting to allow stakeholders additional time for reading and understanding the new chapter. It will be incorporated into USP–NF 2022, Issue 1 on Nov. 1, 2021 and will become official on May 1, 2022.

The chapter can be accessed here. Questions may be directed to Horacio Pappa, senior director of General Chapters, at hp@usp.org.

Source: USP-NF

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Videos
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
© 2025 MJH Life Sciences

All rights reserved.